STOCK TITAN

SOLAI Limited American (SLAI) Financials

SLAI
FY2025 annual
Revenue $23.0M -30.1% YoY
Net Income -$33.9M -380.6% YoY
EPS (Diluted) -$0.02 -300.0% YoY
Free Cash Flow -$27.1M +20.0% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SLAI SEC filings page.

SOLAI Limited American (SLAI) reported $23.0M in revenue for fiscal year 2025, down 30.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLAI FY2025

SOLAI's dominant mechanic is volatile gross economics and operating cash consumption, not balance-sheet leverage.

FY2024's 36.7% net margin sat beside a -24.3% operating margin, so reported profit did not come from the operating business. Operating cash flow was -$32.7M that year, and FY2025 returned to a -$33.9M net loss, making the profit spike look non-operating or non-cash rather than a durable earnings engine.

Gross margin fell from 9.1% in FY2024 to -46.9% in FY2025, a shift that points to worsening unit economics rather than merely slower volume. Revenue contracted 30.1% while SG&A rose to $18.3M, showing that overhead did not adjust with the smaller revenue base.

FY2025 free cash flow of -$27.1M nearly matched operating cash flow of -$26.9M because capital expenditures were only $220K; cash use was primarily operating, not expansionary reinvestment. The balance sheet was lightly leveraged, with debt-to-equity at 0.3x, but reported liquidity equaled only 2.1 months of annual operating outflow, making cash availability more informative than debt burden.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 21 / 100
Financial Health Score 21/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SOLAI Limited American's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
9

SOLAI Limited American held $4.8M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $26.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and SOLAI Limited American scores 9/100 among other emerging companies.

Dilution
0

Not available for SOLAI Limited American, and counted as zero in the overall score.

R&D Intensity
12

SOLAI Limited American spent $874K on research and development in fiscal year 2025, which was 1.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and SOLAI Limited American scores 12/100 among other emerging companies.

Revenue Progress
14

SOLAI Limited American reported revenue of $23.0M in fiscal year 2025, against $32.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and SOLAI Limited American scores 14/100 among other emerging companies.

Burn Trend
48

SOLAI Limited American's operations used $26.9M of cash in fiscal year 2025, against $32.7M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and SOLAI Limited American scores 48/100 among other emerging companies.

Balance Sheet
40

SOLAI Limited American's cash, cash equivalents and investments came to $4.8M at the end of fiscal year 2025, against $10.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and SOLAI Limited American scores 40/100 among other emerging companies.

Altman Z-Score Distress
-19.05

SOLAI Limited American scores -19.05, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($16.7M) relative to total liabilities ($10.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

SOLAI Limited American passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

SOLAI Limited American reported a net loss of $33.9M while operations used $26.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$1.4M
YoY-21.5%
QoQ+15.9%

SOLAI Limited American held $1.4M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

SLAI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLAI quarterly income statement
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'24Q4'23Q2'23Q4'22Q2'22

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

SLAI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLAI quarterly balance sheet
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'24Q4'23Q2'23Q4'22Q2'22
Total Assets$45.6M-47.2%$69.1M+9.2%$86.3M+18.9%$63.3M-23.0%$72.6M-16.4%$82.1M-65.5%$86.8M-70.5%$238.3M-23.8%
Current Assets$17.7M-7.7%$10.5M-65.5%$19.1M-43.4%$30.5M-19.4%$33.9M-4.2%$37.9M-53.7%$35.3M-62.1%$81.7M-40.0%
Cash & Equivalents$1.4M-21.5%$1.2M-46.6%$1.8M-44.2%$2.3M-49.7%$3.2M-41.0%$4.6M-79.8%$5.5M-68.9%$22.6M+122.7%
Accounts Receivable$2.8M+49.6%$1.4M-52.9%$1.8M-35.8%$3.1M-25.7%$2.9M-19.6%$4.1M+229.9%$3.6M+385.1%$1.3M-61.4%
GoodwillN/AN/A$0N/A$0N/AN/A$26.6M-1.1%
Total Liabilities$10.9M-44.4%$15.3M-12.2%$19.6M-58.8%$17.4M-49.7%$47.5M+40.9%$34.6M-36.6%$33.7M-62.1%$54.5M-54.1%
Current Liabilities$10.0M-10.8%$11.3M-27.4%$11.2M-75.0%$15.6M-51.5%$44.9M+45.7%$32.2M-36.7%$30.8M-63.5%$50.9M-56.7%
Non-Current Liabilities$860K-89.7%$3.9M+121.4%$8.3M+227.8%$1.8M-23.7%$2.5M-10.5%$2.3M-34.2%$2.8M-37.9%$3.5M+243.4%
Total Equity$34.2M-39.8%$43.8M-4.5%$56.9M+126.4%$45.9M-3.6%$25.1M-52.7%$47.6M-73.3%$53.1M-70.5%$178.2M-0.5%
Retained Earnings-$591.8M-6.1%-$571.8M-3.8%-$557.9M+2.3%-$551.0M-0.6%-$570.9M-5.3%-$548.0M-34.0%-$542.2M-40.2%-$408.9M-16.4%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Long-Term Debt.

SLAI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLAI quarterly cash flow statement
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'24Q4'23Q2'23Q4'22Q2'22

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

SLAI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLAI quarterly financial ratios
MetricQ4'2520-FQ2'2510-QQ4'2420-FQ2'24Q4'23Q2'23Q4'22Q2'22
Current Ratio1.76+0.1x0.93-1.0x1.70+1.0x1.95+0.8x0.75-0.4x1.17-0.4x1.150.0x1.60+0.4x
Debt-to-Equity0.320.0x0.350.0x0.34-1.5x0.38-0.3x1.89+1.3x0.73+0.4x0.63+0.1x0.31+0.3x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Frequently Asked Questions

What is SOLAI Limited American's annual revenue?

SOLAI Limited American (SLAI) reported $23.0M in total revenue for fiscal year 2025. This represents a -30.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SOLAI Limited American's revenue growing?

SOLAI Limited American (SLAI) revenue declined by 30.1% year-over-year, from $32.9M to $23.0M in fiscal year 2025.

Is SOLAI Limited American profitable?

No, SOLAI Limited American (SLAI) reported a net income of -$33.9M in fiscal year 2025.

SOLAI Limited American (SLAI) reported diluted earnings per share of -$0.02 for fiscal year 2025. This represents a -300.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SOLAI Limited American (SLAI) had EBITDA of -$18.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

SOLAI Limited American (SLAI) had a gross margin of -46.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

SOLAI Limited American (SLAI) has a return on equity of -99.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

SOLAI Limited American (SLAI) recorded an outflow of $27.1M in free cash flow during fiscal year 2025. This represents a 20.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

SOLAI Limited American (SLAI) recorded an outflow of $26.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

SOLAI Limited American (SLAI) had $45.6M in total assets as of fiscal year 2025, including both current and long-term assets.

SOLAI Limited American (SLAI) invested $220K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

SOLAI Limited American (SLAI) invested $874K in research and development during fiscal year 2025.

SOLAI Limited American (SLAI) had 1.87B shares outstanding as of fiscal year 2025.

SOLAI Limited American (SLAI) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.

SOLAI Limited American (SLAI) had a debt-to-equity ratio of 0.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

SOLAI Limited American (SLAI) had a return on assets of -74.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, SOLAI Limited American (SLAI) held $4.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $26.9M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

SOLAI Limited American (SLAI) has an Altman Z-Score of -19.05, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

SOLAI Limited American (SLAI) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SOLAI Limited American (SLAI) reported a net loss of $33.9M while operations used $26.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

SOLAI Limited American (SLAI) scores 21 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top